These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

1126 related articles for article (PubMed ID: 23152559)

  • 1. Tumor-infiltrating monocytic myeloid-derived suppressor cells mediate CCR5-dependent recruitment of regulatory T cells favoring tumor growth.
    Schlecker E; Stojanovic A; Eisen C; Quack C; Falk CS; Umansky V; Cerwenka A
    J Immunol; 2012 Dec; 189(12):5602-11. PubMed ID: 23152559
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-derived chemokine CCL5 enhances TGF-β-mediated killing of CD8(+) T cells in colon cancer by T-regulatory cells.
    Chang LY; Lin YC; Mahalingam J; Huang CT; Chen TW; Kang CW; Peng HM; Chu YY; Chiang JM; Dutta A; Day YJ; Chen TC; Yeh CT; Lin CY
    Cancer Res; 2012 Mar; 72(5):1092-102. PubMed ID: 22282655
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Subsets of myeloid-derived suppressor cells in hepatocellular carcinoma express chemokines and chemokine receptors differentially.
    Zhao W; Xu Y; Xu J; Wu D; Zhao B; Yin Z; Wang X
    Int Immunopharmacol; 2015 Jun; 26(2):314-21. PubMed ID: 25891236
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skewing the Th cell phenotype toward Th1 alters the maturation of tumor-infiltrating mononuclear phagocytes.
    Nonaka K; Saio M; Suwa T; Frey AB; Umemura N; Imai H; Ouyang GF; Osada S; Balazs M; Adany R; Kawaguchi Y; Yoshida K; Takami T
    J Leukoc Biol; 2008 Sep; 84(3):679-88. PubMed ID: 18566103
    [TBL] [Abstract][Full Text] [Related]  

  • 5. CD49d is a new marker for distinct myeloid-derived suppressor cell subpopulations in mice.
    Haile LA; Gamrekelashvili J; Manns MP; Korangy F; Greten TF
    J Immunol; 2010 Jul; 185(1):203-10. PubMed ID: 20525890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CCR5 chemokine receptor mediates recruitment of MHC class II-positive Langerhans cells in the mouse corneal epithelium.
    Yamagami S; Hamrah P; Miyamoto K; Miyazaki D; Dekaris I; Dawson T; Lu B; Gerard C; Dana MR
    Invest Ophthalmol Vis Sci; 2005 Apr; 46(4):1201-7. PubMed ID: 15790880
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary tumor heterogeneity in the expansion of myeloid-derived suppressor cells.
    Donkor MK; Lahue E; Hoke TA; Shafer LR; Coskun U; Solheim JC; Gulen D; Bishay J; Talmadge JE
    Int Immunopharmacol; 2009 Jul; 9(7-8):937-48. PubMed ID: 19362167
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Osteopontin shapes immunosuppression in the metastatic niche.
    Sangaletti S; Tripodo C; Sandri S; Torselli I; Vitali C; Ratti C; Botti L; Burocchi A; Porcasi R; Tomirotti A; Colombo MP; Chiodoni C
    Cancer Res; 2014 Sep; 74(17):4706-19. PubMed ID: 25035397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Virus stimulation of human mast cells results in the recruitment of CD56⁺ T cells by a mechanism dependent on CCR5 ligands.
    McAlpine SM; Issekutz TB; Marshall JS
    FASEB J; 2012 Mar; 26(3):1280-9. PubMed ID: 22125314
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Differential regulatory effects of chemotherapeutic protocol on CCL3_CCL4_CCL5/CCR5 axes in acute myeloid leukemia patients with monocytic lineage.
    Yazdani Z; Mousavi Z; Ghasemimehr N; Kalantary Khandany B; Nikbakht R; Jafari E; Fatemi A; Hassanshahi G
    Life Sci; 2020 Jan; 240():117071. PubMed ID: 31783051
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pam2 lipopeptides systemically increase myeloid-derived suppressor cells through TLR2 signaling.
    Maruyama A; Shime H; Takeda Y; Azuma M; Matsumoto M; Seya T
    Biochem Biophys Res Commun; 2015 Feb; 457(3):445-50. PubMed ID: 25596131
    [TBL] [Abstract][Full Text] [Related]  

  • 12. T regulatory cell chemokine production mediates pathogenic T cell attraction and suppression.
    Patterson SJ; Pesenacker AM; Wang AY; Gillies J; Mojibian M; Morishita K; Tan R; Kieffer TJ; Verchere CB; Panagiotopoulos C; Levings MK
    J Clin Invest; 2016 Mar; 126(3):1039-51. PubMed ID: 26854929
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Adoptive cytotoxic T lymphocyte therapy triggers a counter-regulatory immunosuppressive mechanism via recruitment of myeloid-derived suppressor cells.
    Hosoi A; Matsushita H; Shimizu K; Fujii S; Ueha S; Abe J; Kurachi M; Maekawa R; Matsushima K; Kakimi K
    Int J Cancer; 2014 Apr; 134(8):1810-22. PubMed ID: 24150772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. I-TAC/CXCL11 is a natural antagonist for CCR5.
    Petkovic V; Moghini C; Paoletti S; Uguccioni M; Gerber B
    J Leukoc Biol; 2004 Sep; 76(3):701-8. PubMed ID: 15178708
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-induced myeloid-derived suppressor cell subsets exert either inhibitory or stimulatory effects on distinct CD8+ T-cell activation events.
    Schouppe E; Mommer C; Movahedi K; Laoui D; Morias Y; Gysemans C; Luyckx A; De Baetselier P; Van Ginderachter JA
    Eur J Immunol; 2013 Nov; 43(11):2930-42. PubMed ID: 23878002
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of CCR5 and its ligands CCL3, -4, and -5 in the tear film and ocular surface of patients with dry eye disease.
    Choi W; Li Z; Oh HJ; Im SK; Lee SH; Park SH; You IC; Yoon KC
    Curr Eye Res; 2012 Jan; 37(1):12-7. PubMed ID: 22029739
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of a chemokine network that recruits FoxP3(+) regulatory T cells into chronically inflamed intestine.
    Kang SG; Piniecki RJ; Hogenesch H; Lim HW; Wiebke E; Braun SE; Matsumoto S; Kim CH
    Gastroenterology; 2007 Mar; 132(3):966-81. PubMed ID: 17324406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T cells stimulate B7-H1 expression in myeloid-derived suppressor cells in ret melanomas.
    Fujimura T; Ring S; Umansky V; Mahnke K; Enk AH
    J Invest Dermatol; 2012 Apr; 132(4):1239-46. PubMed ID: 22189788
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2.
    Zhang Y; Liu Q; Zhang M; Yu Y; Liu X; Cao X
    J Immunol; 2009 Mar; 182(6):3801-8. PubMed ID: 19265159
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myeloid derived suppressor cells and their role in tolerance induction in cancer.
    Fujimura T; Mahnke K; Enk AH
    J Dermatol Sci; 2010 Jul; 59(1):1-6. PubMed ID: 20570112
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 57.